Nalaganje...
EMERGING DRUG PROFILE: Enhancer of Zeste Homolog 2 (EZH2) Inhibitors
Dysregulation of the histone methyltransferase EZH2 plays a critical role in the development of a variety of malignancies including B-cell lymphomas. As a result, a series of small molecule inhibitors of EZH2 have been developed and studied in the pre-clinical setting. Three EZH2 inhibitors: tazemet...
Shranjeno v:
| izdano v: | Leuk Lymphoma |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6659997/ https://ncbi.nlm.nih.gov/pubmed/29473431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2018.1430795 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|